ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Juvenile idiopathic arthritis"

  • Abstract Number: 0717 • ACR Convergence 2020

    Predictors of Clinical Remission in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis Treated with Etanercept in the CLIPPER Studies

    Jelena Vojinovic1, Vyacheslav Chasnyk1, Joke Dehoorne1, Violeta Panaviene1, Jonathan Akikusa2, Tadej Avcin1, Jeffrey Chaitow1, Bernard Lauwerys1, Jordi Antón1, Inmaculada Penades1, Berit Flato1, Alina Boteanu3, Hans-Iko Huppertz1, Juan Jaller1, Daniela Graham4, Cecilia Borlenghi5, Bonnie Vlahos6, Chuanbo Zang6 and Nicolino Ruperto2, 1Paediatric Rheumatology International Trials Organisation (PRINTO), Genoa, Italy, 2PRINTO, Istituto Giannina Gaslini, Genova, Italy, 3Hospital Universitario Ramón y Cajal, Madrid, Spain, 4Pfizer, Groton, PA, 5Pfizer, New York, NY, 6Pfizer, Collegeville, PA

    Background/Purpose: CLIPPER is an ongoing, 8-year, phase 3b, multicenter, open-label study of the safety and efficacy of etanercept in the treatment of juvenile idiopathic arthritis…
  • Abstract Number: 1150 • ACR Convergence 2020

    Traditional Laboratory Parameters and New Biomarkers in Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis

    Arianna De Matteis1, Denise Pires Marafon1, Ivan Caiello1, Manuela Pardeo1, Giulia Marucci1, Emanuela Sacco1, Giusi Prencipe1, Fabrizio De Benedetti2 and Claudia Bracaglia1, 1Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 2Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy

    Background/Purpose: Macrophage Activation Syndrome (MAS) and secondary Hemophagocytic Lymphohistiocytosis (sHLH) are hyperinflammatory conditions caused by a cytokine storm, in which IFNγ plays a pivotal role.…
  • Abstract Number: 1984 • ACR Convergence 2020

    Causal Pathways to Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the ReACCh-Out Cohort

    Kiem Oen1, Jiahao Tian2, Thomas Loughin2, Roberta Berard3, Mercedes Chan4, Ciaran Duffy5, Brian Feldman6, Adam Huber7, Deborah Levy8, Dax G. Rumsey9, Natalie Shiff10, Shirley Tse11, Lori Tucker4, Karen Watanabe-Duffy5 and Jaime Guzman12, 1University of Manitoba, Toronto, ON, Canada, 2Simon Fraser University, Burnaby, BC, Canada, 3London Health Sciences Centre, London, ON, Canada, 4BC Children's Hospital, Vancouver, BC, Canada, 5Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Dalhousie University, Halifax, NS, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 9University of Alberta, Edmonton, AB, Canada, 10Florida, Gainesville, FL, 11SickKids, Toronto, ON, Canada, 12University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: The relative roles of disease activity and disability as determinants of health-related quality of life (HRQoL) in children with JIA have been controversial; sometimes…
  • Abstract Number: 0039 • ACR Convergence 2020

    Identification of a Regulatory Pathway Governing Expression of TRAF1 via a JIA-associated Non-coding Variant

    Qiang Wang1, Marta Martínez2, Matthew Weirauch3 and Peter Nigrovic4, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, 3Cincinnati Children’s Hospital Medical Center/Univ of Cincinnati, 535 Terrace Ave, 4Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA, Boston

    Background/Purpose: Over the past decade, genome-wide association studies (GWAS) have identified TRAF1/C5 locus as a risk locus for rheumatoid diseases including RA and JIA(Plenge, Seielstad…
  • Abstract Number: 0718 • ACR Convergence 2020

    Obesity Impairs Achievement of Clinical Inactive Disease (CID) in Patients with Juvenile Idiopathic Arthritis (JIA) Treated with TNF Inhibitors

    Fabio Basta1, Denise Pires Marafon2, Angela Aquilani3, Maria Isabella Petrone4, Andrea Uva5, Hanan Jadoun6, Aurora Puccacco2, Rebecca Nicolai6, Silvia Magni Manzoni2 and Fabrizio De Benedetti7, 11 Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy 2 University Center of Autoimmunity, Johannes Gutenberg-University, Mainz, Germany 3 Acura Rheumatology Center Rhineland Palatinate, Bad Kreuznach, Germany, Mainz, Rheinland-Pfalz, Germany, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 3Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Lazio, Italy, 4Dipartimento Pediatrico Universitario Ospedaliero, Tor Vergata University, Roma, Italy, 5Dipartimento Materno-Infantile e Scienze Urologiche, La Sapienza University, Rome, Italy, 6Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Lazio, Italy, 7Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy

    Background/Purpose: to assess prevalence and disease features associated with obesity in juvenile idiopathic arthritis (JIA) and to evaluate the impact of obesity on the achievement…
  • Abstract Number: 1152 • ACR Convergence 2020

    IL-18: A Biomarker That Reflects Disease Activity, Could It Be the Next Disease Activity Measure in Systemic Juvenile Idiopathic Arthritis?

    Shima Yasin1, Thuy Do2, Sanjeev Dhakal2, Elizabeth Baker2, Alexei Grom3 and Grant Schulert4, 1Cincinnati Children's Hospital Medical Center, Liberty twp, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnati, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) is a childhood arthritis with prominent innate immune activity. Disease presentation and flares could largely mimic infections with fever…
  • Abstract Number: 1985 • ACR Convergence 2020

    Validity and Reliability of Four Parent/Patient Reported Outcome Measures for Juvenile Idiopathic Arthritis

    Chiara Trincianti1, E. H. Pieter Van Dijkhuizen2, Serena Calandra3, Helga Sanner4, Tamas Constantin5, Troels Herlin6, Marco Cattalini7, Flavio Sztajnbok8, Despoina Maritsi9, Nicolino Ruperto10, Angelo Ravelli11 and Alessandro Consolaro11, 1Istituto Giannina Gaslini, Genova, Liguria, Italy, 2Wilhelmina Children’s Hospital, Utrecht, Netherlands, 3IRCCS Istituto Giannina Gaslini, Genoa, Liguria, Italy, 4Oslo University Hospital, Oslo, Norway, 5Semmelweis University, Budapest, Hungary, 6Aarhus University Hospital, Aarhus, Denmark, 7Università di Brescia, Brescia, Italy, 8Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 9National and Kapodistrian University of Athens, Athens, Greece, 10Istituto Giannina Gaslini, Genova, Italy, 11Università degli Studi di Genova, Genoa, Italy

    Background/Purpose: In the last years, the interest in the assessment of parent- and child-reported outcomes (PCROs) in paediatric rheumatic diseases is gaining increasing importance. These…
  • Abstract Number: 0084 • ACR Convergence 2020

    Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort

    Natalia Cabrera1, Vannia Valinotti2, Gabriela Avila-Pedretti1, Sonia Cabrera2, Patricia Melgarejo3, Zoilo Morel4, Lourdes Roman2, Pedro Babak4, Rodrigo Acosta2, Romina Glitz4, Darwin Cordovilla5, Roger Rolon4, Magali Zanotti-Cavazzoni1, Marco Antonio Franco Britos6, Marcos Vazquez2, Pedro Delgadillo4, Isabel Acosta2, María del Carmen Martinez4, Gabriel Elizaur4, María Teresa Romero4, Ernesto Paredes4, Paloma de Abreu1 and Leticia Segovia7, 1Sociedad Paraguaya de Reumatología, Asunción, Paraguay, 2Hospital de Clínicas, Asunción, Paraguay, 3Hospital IPS, Villa Rica, Paraguay, 4Hospital Central del Instituto de Previsión Social, Asunción, Paraguay, 5Instituto Nacional de Reumatología, Montevideo, Uruguay, 6Instituto de Previsi�n Social, Asunci�n, Central, Paraguay, 7Hospital del IPS, Asunción, Paraguay

    Background/Purpose: The Paraguayan-Uruguayan cohort of patients with rheumatic inflammatory diseases (BIOBADAGUAY), collect clinical and epidemiological information on adults and children patients receiving biological therapies (BT).…
  • Abstract Number: 0720 • ACR Convergence 2020

    Long Term Efficacy and Safety of Triamcinolone Hexacetonide versus Triamcinolone Acetonide Intraarticular Injection for Juvenile Idiopathic Arthritis

    Shiri Rubin1, Orly Ohana1, Ori Goldberg2, Yulia Gendler1, Zohar Habot-Wilner3, Rotem Tal4, Yoel Levinski5, Liora Harel6 and Gil Amarilyo7, 1Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 2Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel, Petach Tikva, Israel, 3Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel, 41Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 5Schneider Children's Medical Center of Israel,3Tel Aviv University, Tel Aviv, Israel, Petach Tikva, Israel, 6Scheider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel, Petach Tikva, Israel, 7Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel,, Petach Tikva, Israel

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood. Intra-articular corticosteroids joint injection (IAJI) with Triamcinolone hexacetonide (TH) or triamcinolone acetonide…
  • Abstract Number: 1153 • ACR Convergence 2020

    Trends in Timing of Biologic Use for Treatment of Systemic Juvenile Idiopathic Arthritis in the CARRA Registry

    Ginger Janow1, Timothy Beukelman2, Yukiko Kimura3, Rayfel Schneider4, Shalini Mohan5, Gail Rodich6 and Mary Beth Son7, 1Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health, Hackensack, NJ, 2University of Alabama at Birmingham, Birmingham, AL, 3Hackensack Meridian School of Medicine, Hackensack, NJ, 4University of Toronto, The Hospital for Sick Children, Toronto, Canada, 5Genentech, Inc., South San Francisco, CA, 6Genentech, Mill Valley, CA, 7Boston Children's Hospital, Boston, MA

    Background/Purpose: The treatment of systemic juvenile idiopathic arthritis (SJIA) has changed dramatically over the past decade, associated with overall improvement in functional outcomes.  There may…
  • Abstract Number: 0164 • ACR Convergence 2020

    What’s in a Name? Patient and Family Perspectives on the Naming of Systemic Juvenile Idiopathic Arthritis

    Mariana Correia Marques1, Rashmi Sinha2, Karen Durrant3, Sivia Lapidus4, Nicole Tennermann5, Saskya Angevare6, Leah Bush7, Kari Cupp8, Jonathan Hausmann9, David Maher10, Shalla Newton10, Michael Ombrello11, Phillip Reardon8, Rebecca Trachtman12, Fatma Dedeoglu5 and Grant Schulert13, 1Boston Children`s Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, 2SJIA Foundation, Cincinnati, 3Autoinflammatory Alliance, San Francisco, CA, 4The Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Montclair, NJ, 5Boston Children's Hospital, Boston, MA, 6Autoinflammatory Alliance, Amersfoort, Netherlands, 7Systemic JIA Foundation, Cincinnati, OH, 8Systemic JIA Foundation, Cincinnati, 9Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 10Still's Disease, the 411, National organization, 11Translational Genetics and Genomics Unit, NIAMS, NIH, Bethesda, MD, 12Icahn School of Medicine at Mount Sinai, New York, NY, 13PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: The childhood inflammatory disorder systemic juvenile idiopathic arthritis (SJIA) has historically had several names, including Still’s disease and systemic juvenile rheumatoid arthritis. While its…
  • Abstract Number: 0722 • ACR Convergence 2020

    Evaluation of Flare Rate and Tapering Strategies in Juvenile Idiopathic Arthritis

    Antía García-Fernández1, Andrea Briones-Figueroa1, Laura Calvo-Sanz1, África Andreu Suárez1 and Alina Lucica Boteanu2, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2PRINTO, Istituto Giannina Gaslini, Genova, Italy

    Background/Purpose: Biological treatment (BT) has changed the perspectives of Juvenile Idiopathic Arthritis (JIA) patients, but it remains unclear when and how to taper or to withdraw…
  • Abstract Number: 1154 • ACR Convergence 2020

    Distinct Gene Signature Predicts Strong Clinical Responses to Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis

    Emely Verweyen1, Alex Pickering2, Alexei Grom3 and Grant Schulert4, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Harvard Medical School, Boston, MA, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4PRCSG, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Canakinumab is a human anti-IL1β blocking agent that effectively neutralizes IL1β mediated signaling and is used to treat diseases such as systemic juvenile idiopathic…
  • Abstract Number: 0172 • ACR Convergence 2020

    Early Treatment and IL1RN Single Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic Arthritis

    Marianna Nicoletta Rossi1, Manuela Pardeo2, Denise Pires Marafon2, Emanuela Sacco2, Chiara Passarelli3, Claudia Bracaglia2, Chiara Perrone3, Anna Tulone4, Giusi Prencipe5 and Fabrizio De Benedetti6, 1Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Lazio, Italy, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 3U.O.C. Laboratory of Medical Genetics, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 4Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 5Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Italy, 6Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy

    Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) represents 10-20% of all chronic arthritis during childhood. The interleukin 1 (IL-1) play a pivotal role in the pathogenesis…
  • Abstract Number: 0723 • ACR Convergence 2020

    Social Determinants of Health and Time to First Pediatric Rheumatology Appointment in Polyarticular Juvenile Idiopathic Arthritis

    Nayimisha Balmuri1, Victoria Cooley2, Linda Gerber2, Susan Goodman3, Bella Mehta3 and Karen Onel4, 1Hospital for Special Surgery, new york, NY, 2Weill Cornell Medicine, NY, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Pediatric Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients with polyarticular JIA (pJIA) have a refractory disease course with increased risk for joint damage resulting in poor functional outcome and decreased quality of…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.